Abstract
In this issue of Blood, Kreitman and colleagues update results of a study of moxetumomab pasudotox in patients with relapsed hairy cell leukemia (HCL)......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
